Reports

Agnes Dr. Brandt

Agnes Dr. Brandt

Dr. Agnes Brandt is a highly experienced lobbyist specializing in EU policy and regulatory affairs, particularly focusing on health and climate policy. She serves as a Director at Brunswick Group’s Brussels office, leveraging extensive expertise from roles in European Parliament and specialized health policy consultancies. With a rich background that includes academic research in Germany and New Zealand, she brings a deep understanding of how politics intersects with socio-cultural and economic issues impacting public health and environmental sustainability. Agnes has led diverse public affairs programs at both European and global levels, helping clients navigate complex regulatory environments and drive impactful policy outcomes. She is fluent in English, German, and French, which supports her work across the EU and international settings.

While Agnes Brandt primarily operates out of Brussels within the EU policy context, her role at Brunswick Group entails advising global clients—including those with interests in or linked to the UK—on navigating the overlapping regulatory landscapes of the EU and the UK, especially post-Brexit. Through this work, she supports UK-related stakeholders who require expert insight into EU health, climate, and regulatory policies that affect UK businesses and institutions indirectly or through cooperation agreements.

Her lobbying activities on behalf of clients connected to the UK include:

  • Strategically guiding UK clients on adapting to EU health and climate regulations, which remain critical due to the close economic and political ties between the UK and EU member states.

  • Advocating for policies that align with sustainable development and climate initiatives where UK firms and organizations seek influence or partnership across EU institutions.

  • Facilitating stakeholder engagement for UK entities within EU decision-making bodies to maintain their competitiveness in life sciences, healthcare, biotech, and environmental sectors.

  • Helping UK clients anticipate regulatory changes emanating from Brussels that impact their operations or market access, aiming to shape favorable policy environments.

Dr. Brandt’s true and nuanced intention often extends beyond direct lobbying for UK interests. By positioning herself and Brunswick Group as key connectors between EU and UK policy circles, she effectively fosters transnational collaboration that benefits her clients’ strategic goals. This careful positioning also accommodates shifting political contexts, ensuring that UK-related lobbying efforts remain relevant regardless of evolving EU-UK political relations.

Dr. Agnes Brandt’s lobbying activities are comprehensive and centered on promoting her clients’ interests by engaging proactively with EU policymakers. Key elements include:

  • Leading public affairs campaigns on health and climate change policy, areas where the EU has significant regulatory influence.

  • Organizing and participating in strategic meetings with Members of the European Parliament (MEPs), European Commission officials, and other influential EU stakeholders. For example, her prior role as head of office for a leading MEP on health, climate, and environment provided her with valuable networks and insights.

  • Influencing legislative and regulatory processes through coalition-building with NGOs, industry groups, and other stakeholders to shape policies that favor her clients’ objectives.

  • Running targeted advocacy projects that align with client priorities, such as sustainable healthcare innovations or climate resilience initiatives within EU regulatory frameworks.

Specific meetings and their influence can be summarized as follows:

  • Participation in trilogue negotiations and committee engagements within the European Parliament, influencing outcomes related to health directives and environmental regulations.

  • Engagement with key committees handling climate change and public health, where her expertise and client interests converge to promote progressive policies.

  • Collaborative dialogues with EU institutions to ensure that evolving health and climate policies are considerate of her clients’ operational and strategic necessities.

These activities have contributed to measurable impact, such as shaping EU policies favorable to innovation in healthcare and climate sectors, indirectly supporting UK businesses intertwined with EU markets and regulatory system

X-twitter Youtube